QC
BLUE

Quent Capital’s bluebird bio BLUE Stock Holding History

Quent Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,650
Closed -$45.5K – 1362
2023
Q4 		$45.5K Hold
1,650
– – 0.01% 639
2023
Q3 		$100K Hold
1,650
– – 0.02% 406
2023
Q2 		$109K Hold
1,650
– – 0.02% 407
2023
Q1 		$104K Hold
1,650
– – 0.02% 408
2022
Q4 		$228K Hold
1,650
– – 0.04% 241
2022
Q3 		$209K Buy
+1,650
New +$187K 0.04% 242

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Quent Capital's BLUE Position: Q1 2024 in Review

Quent Capital sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 1,650 shares — an estimated $45.5K sold.

Quent Capital first reported a position in BLUE in Q3 2022 and held it in 6 quarters. The position peaked at $228K in Q4 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Quent Capital reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Quent Capital sold 1,650 bluebird bio shares in Q1 2024, an estimated $45.5K.
  • Quent Capital first reported a position in bluebird bio in Q3 2022 and held it in 6 quarters.
  • Quent Capital's bluebird bio position peaked at $228K in Q4 2022.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Quent Capital's 13F filing for Q1 2024, filed 2 May 2024.